Tufts CSDD shows multi-million dollar benefits of Translational Pharmaceutics

The outcomes from this research indicate that Translational Pharmaceutics can create substantial time savings and financial benefits to pharma and biotech companies

picture of

Breaking News

MIT spinout designs gentle process for billions of engineered cells in minutes

Kytopen has engaged Cambridge Consultants to co-develop the first Flowfect system using continuous fluid flow combined ...

3i builds single-use bioprocessing platform using three acquisitions

The UK-based company has acquired Cellon, Silicone Altimex and TBL Performance Plastics to establish a platform serving ...

Genopis plans plasmid CDMO business launch

Helixmith US-based spinout has capitalised on its pDNA manufacturing experience with plans to launch a CDMO business

Integrated solutions offer fast-track development for biopharmaceuticals

At the heart of any successful medicine launch is a robust manufacturing process that will reliably make the product in ...

Porton Pharma Solutions opens new fermentation pilot lab in China

New fermentation capacity has enabled Porton to deliver kilogram level enzyme powder preparation to meet pilot-scale ...

Evotec agrees to give US Merck access to facility of the future

MSD has paid $15m to gain access to Just–Evotec Biologics’ J.POD Washington facility that conducts small, ...

Medical cannabis made in Italy

Dr Fabio Di Francesco, a compounding pharmacist based in Rome, describes how cannabis is used in various dosage forms ...

Collaboration aims to commercialise regenerative medicine technology

Hitachi Chemical Advanced Therapeutics Solutions and Ori Biotech have agreed to work together to progress Ori’s ...

NIBRT launches first online biopharma manufacturing programme

NIBRT Online Academy is online training that has been designed to assist with the skills and career development of ...

Optimising viral vector production for biologics

To overcome existing challenges in viral vector production, Belgium-based Univercells has worked to develop an ...

Future market dynamics and opportunities in immuno-oncology

Long-term survival, tumour-agnostic effects and the potential for cure in a fraction of patients are key catalysts ...

Lonza reveals process development roadmap for cell and gene therapies

Behnam Baghbaderani of Lonza Pharma & Biotech examines four manufacturing challenges inherent to the production of ...

Eli Lilly makes $1.1bn biopharma acquisition

Pharma giant Eli Lilly has agreed to acquire chronic skin condition-focused biopharma Dermira

US gene therapy CDMO enters virus manufacturing partnership

Vigene Biosciences will provide manufacturing services for ASC for both early-stage and commercial virus production